PMID- 16756618 OWN - NLM STAT- MEDLINE DCOM- 20060724 LR - 20161124 IS - 0161-3499 (Print) IS - 0161-3499 (Linking) VI - 35 IP - 4 DP - 2006 Jun TI - Proinflammatory cytokine activities, matrix metalloproteinase-3 activity, and sulfated glycosaminoglycan content in synovial fluid of dogs with naturally acquired cranial cruciate ligament rupture. PG - 369-76 AB - OBJECTIVE: To measure and compare activities of interleukin-1beta (IL-1beta), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and matrix metalloproteinase-3 (MMP-3); as well as sulfated glycosaminoglycan (S-GAG) content in synovial fluid from dogs with cranial cruciate ligament rupture (CCLR) and dogs with clinically normal stifles. To determine whether correlations exist between demographic and disease-related variables and these synovial markers. STUDY DESIGN: Prospective clinical study. ANIMALS: Dogs with CCLR (n=23) and Beagles with normal stifle joints (n=21). METHODS: Synovial fluid activities of proinflammatory cytokines (IL-1beta, IL-6, and TNF-alpha) were determined by bioassay. MMP-3 activity was measured using fluorogenic substrate. S-GAG contents were determined by dimethylmethylene blue dye-binding assay. Mann-Whitney U-test was used to compare results from CCLR joints with normal controls. Spearman's rank correlation test was used to evaluate associations between demographic and disease-related markers and synovial markers. RESULTS: Mean values for synovial markers were significantly higher in CCLR joints compared with controls. IL-1beta and MMP-3 were positively correlated with lameness duration. CONCLUSIONS: Activities of proinflammatory cytokines, MMP-3 activity and S-GAG contents were significantly elevated in synovial fluid from canine stifle joints with naturally acquired CCLR. These results indicate that there is joint inflammation and increased release of GAGs into synovial fluid, suggesting that these inflammatory changes are associated with depletion of proteoglycan from articular cartilage. CLINICAL RELEVANCE: Medical and surgical treatments designed to decrease joint inflammation and breakdown of proteoglycans may be of value in the management of CCLR in the dog. FAU - Fujita, Yukihiro AU - Fujita Y AD - Division of Veterinary Surgery, Department of Veterinary Science, Faculty of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan. y-fujita@zb3.so-net.ne.jp FAU - Hara, Yasushi AU - Hara Y FAU - Nezu, Yoshinori AU - Nezu Y FAU - Schulz, Kurt S AU - Schulz KS FAU - Tagawa, Masahiro AU - Tagawa M LA - eng PT - Journal Article PL - United States TA - Vet Surg JT - Veterinary surgery : VS JID - 8113214 RN - 0 (Biomarkers) RN - 0 (Cytokines) RN - 0 (Glycosaminoglycans) RN - 0 (Interleukin-1) RN - 0 (Interleukin-6) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) SB - IM MH - Animals MH - *Anterior Cruciate Ligament Injuries MH - Biomarkers/metabolism MH - Case-Control Studies MH - Cytokines/metabolism MH - Dogs/*injuries/surgery MH - Female MH - Glycosaminoglycans/metabolism MH - Injury Severity Score MH - Interleukin-1/metabolism MH - Interleukin-6/metabolism MH - Knee Injuries/diagnostic imaging/metabolism/surgery/*veterinary MH - Male MH - Matrix Metalloproteinase 3/metabolism MH - Prospective Studies MH - Radiography MH - Synovial Fluid/*metabolism MH - Tumor Necrosis Factor-alpha/metabolism EDAT- 2006/06/08 09:00 MHDA- 2006/07/25 09:00 CRDT- 2006/06/08 09:00 PHST- 2006/06/08 09:00 [pubmed] PHST- 2006/07/25 09:00 [medline] PHST- 2006/06/08 09:00 [entrez] AID - VSU00159 [pii] AID - 10.1111/j.1532-950X.2006.00159.x [doi] PST - ppublish SO - Vet Surg. 2006 Jun;35(4):369-76. doi: 10.1111/j.1532-950X.2006.00159.x.